These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2056 related items for PubMed ID: 11519503

  • 1. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
    Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators.
    N Engl J Med; 2001 Aug 16; 345(7):494-502. PubMed ID: 11519503
    [Abstract] [Full Text] [Related]

  • 2. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E, CLARITY-TIMI 28 Investigators.
    N Engl J Med; 2005 Mar 24; 352(12):1179-89. PubMed ID: 15758000
    [Abstract] [Full Text] [Related]

  • 3. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial.
    Circulation; 2004 Sep 07; 110(10):1202-8. PubMed ID: 15313956
    [Abstract] [Full Text] [Related]

  • 4. Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
    APPRAISE Steering Committee and InvestigatorsDuke Clinical Research Institute, Duke University Medical Center, DUMC Box 3850, Durham, NC 27715, USA. john.h.alexander@duke.edu, Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo W, Verheugt F, Wallentin L.
    Circulation; 2009 Jun 09; 119(22):2877-85. PubMed ID: 19470889
    [Abstract] [Full Text] [Related]

  • 5. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
    Zeymer U, Gitt A, Jünger C, Bauer T, Heer T, Koeth O, Mark B, Zahn R, Senges J, Gottwik M.
    Thromb Haemost; 2008 Jan 09; 99(1):155-60. PubMed ID: 18217148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M, Latsios G, Aggelis D, Bosinakou I, Karambelas I, Tousoulis D, Toutouzas K, Stefanadis C.
    Clin Ther; 2006 Jun 09; 28(6):860-71. PubMed ID: 16860169
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.
    N Engl J Med; 2005 Mar 31; 352(13):1293-304. PubMed ID: 15753114
    [Abstract] [Full Text] [Related]

  • 10. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL, Topol EJ, Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee.
    Am Heart J; 2004 Aug 31; 148(2):263-8. PubMed ID: 15308995
    [Abstract] [Full Text] [Related]

  • 11. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    Warfarin Antiplatelet Vascular Evaluation Trial InvestigatorsMcMaster University, Hamilton, ON, Canada. anands@mcmaster.ca, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, Sussex B, Liu L, Guzman R, Cina C, Crowell R, Keltai M, Gosselin G.
    N Engl J Med; 2007 Jul 19; 357(3):217-27. PubMed ID: 17634457
    [Abstract] [Full Text] [Related]

  • 12. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, Diaz R, Commerford PJ, Valentin V, Yusuf S, Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators.
    Circulation; 2003 Oct 07; 108(14):1682-7. PubMed ID: 14504182
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G, Marin-Neto JA, Parsons LS, Canto JG, Rogers WJ, National Registry of Myocardial Infarction-4.
    Am J Cardiol; 2006 Nov 01; 98(9):1125-31. PubMed ID: 17056312
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS, Morrow DA, Dalby A, Pfisterer M, Duris T, Lopez-Sendon J, Murphy SA, Gao R, Antman EM, Braunwald E, ExTRACT-TIMI 25 Investigators.
    J Am Coll Cardiol; 2007 Jun 12; 49(23):2256-63. PubMed ID: 17560290
    [Abstract] [Full Text] [Related]

  • 15. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
    Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, Mehta SR, Yusuf S, CURE Trial Investigators.
    Eur J Cardiovasc Prev Rehabil; 2007 Apr 12; 14(2):312-8. PubMed ID: 17446813
    [Abstract] [Full Text] [Related]

  • 16. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.
    Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, Dibenedetto D, Eagle KA, Mehta RH, GRACE Investigators.
    Eur Heart J; 2005 Jun 12; 26(11):1063-9. PubMed ID: 15716281
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.
    Valgimigli M, Campo G, de Cesare N, Meliga E, Vranckx P, Furgieri A, Angiolillo DJ, Sabatè M, Hamon M, Repetto A, Colangelo S, Brugaletta S, Parrinello G, Percoco G, Ferrari R, Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators.
    Circulation; 2009 Jun 30; 119(25):3215-22. PubMed ID: 19528337
    [Abstract] [Full Text] [Related]

  • 19. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.
    Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators.
    N Engl J Med; 2006 Apr 20; 354(16):1706-17. PubMed ID: 16531616
    [Abstract] [Full Text] [Related]

  • 20. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS, Mehta SR, Fox KA, Halon DA, Zhao F, Peters RJ, Keltai M, Budaj A, Yusuf S, CURE trial investigators.
    Am Heart J; 2005 Dec 20; 150(6):1177-84. PubMed ID: 16338255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 103.